Article
Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia.
British journal of haematology - 1 Dec 2017
Wolach Ofir, Amitai Irina, DeAngelo Daniel J
Abstract excerpt
Significant advances have been made in recent years in the field of Philadelphia-negative acute lymphoblastic leukaemia (ALL). New insights into the biology and genetics of ALL as well as novel clinical observations and new drugs are changing the way we diagnose, risk-stratify and treat adult patients with ALL. New genetic subtypes and alterations refine risk stratification and uncover new actionable therapeutic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
